Literature DB >> 2631880

Non-secretion of blood group antigens and susceptibility to infection by Candida species.

S M Thom1, C C Blackwell, C J MacCallum, D M Weir, R P Brettle, D F Kinane, D Wray.   

Abstract

One of the innate defences against superficial infections by Candida species appears to be the ability of an individual to secrete the water-soluble form of his ABO blood group antigens into body fluids. There was a significantly higher number of non-secretors (48.9%) among 174 patients with either oral or vaginal candida infections compared with the proportion of non-secretors in the local population (26.6%). The protective effect afforded by the secretor gene might be due to the ability of glycocompounds in the body fluids of secretors to inhibit adhesins on the surface of the yeast. In attachment studies, preincubation of blastospores with boiled secretor saliva significantly reduced their ability to bind to epithelial cells. Non-secretor saliva did not reduce the binding and often enhanced the numbers of attached yeasts. Possible host-parasite interactions underlying the susceptibility of non-secretors to candida and other infections are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2631880     DOI: 10.1111/j.1574-6968.1989.tb02428.x

Source DB:  PubMed          Journal:  FEMS Microbiol Immunol        ISSN: 0920-8534


  23 in total

1.  Blood group antigen expression is involved in C. albicans interaction with buccal epithelial cells.

Authors:  Arun V Everest-Dass; Daniel Kolarich; Dana Pascovici; Nicolle H Packer
Journal:  Glycoconj J       Date:  2016-09-17       Impact factor: 2.916

Review 2.  Intestinal fucose as a mediator of host-microbe symbiosis.

Authors:  Joseph M Pickard; Alexander V Chervonsky
Journal:  J Immunol       Date:  2015-06-15       Impact factor: 5.422

3.  Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.

Authors:  Craig Lammert; Brian D Juran; Erik Schlicht; Xiao Xie; Elizabeth J Atkinson; Mariza de Andrade; Konstantinos N Lazaridis
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-16       Impact factor: 11.382

4.  Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.

Authors:  Dermot P B McGovern; Michelle R Jones; Kent D Taylor; Kristin Marciante; Xiaofei Yan; Marla Dubinsky; Andy Ippoliti; Eric Vasiliauskas; Dror Berel; Carrie Derkowski; Deb Dutridge; Phil Fleshner; David Q Shih; Gil Melmed; Emebet Mengesha; Lily King; Sheila Pressman; Talin Haritunians; Xiuqing Guo; Stephan R Targan; Jerome I Rotter
Journal:  Hum Mol Genet       Date:  2010-06-22       Impact factor: 6.150

5.  The Human Glycoprotein Salivary Agglutinin Inhibits the Interaction of DC-SIGN and Langerin with Oral Micro-Organisms.

Authors:  Martine A Boks; Sabrina T G Gunput; Ilona Kosten; Susan Gibbs; Sandra J van Vliet; Antoon J M Ligtenberg; Yvette van Kooyk
Journal:  J Innate Immun       Date:  2016-04-16       Impact factor: 7.349

6.  Chronic atrophic oral candidiasis among patients with diabetes mellitus--role of secretor status.

Authors:  F Z Aly; C C Blackwell; D A MacKenzie; D M Weir; R A Elton; C G Cumming; J A Sofaer; B F Clarke
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

7.  Association between secretor status and respiratory viral illness.

Authors:  M W Raza; C C Blackwell; P Molyneaux; V S James; M M Ogilvie; J M Inglis; D M Weir
Journal:  BMJ       Date:  1991-10-05

8.  Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease.

Authors:  W Dickey; J S Collins; R G Watson; J M Sloan; K G Porter
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

9.  Association between gastrointestinal tract carriage of Candida, blood group O, and nonsecretion of blood group antigens in patients with peptic ulcer.

Authors:  A P Burford-Mason; J M Willoughby; J C Weber
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

Review 10.  Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review.

Authors:  Luca Maroni; Stan F J van de Graaf; Simon D Hohenester; Ronald P J Oude Elferink; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.